Synthesis, and structure–activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds

European Journal of Medicinal Chemistry
2015.0

Abstract

Combination of the Suzuki cross-coupling and nucleophilic aromatic substitution of hydrogen (SN(H)) reactions proved to be a convenient method for the synthesis of C(4) and/or C(5) mono(thienyl) and di(thienyl) substituted pyrimidines from commercially available 5-bromopyrimidine. All new pyrimidines were found to be active in micromolar concentrations in vitro against H37Rv, avium, terrae, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. The data for acute in vivo toxicity in mice have been obtained for these compounds which appear to be promising antitubercular agents.

Knowledge Graph

Similar Paper

Synthesis, and structure–activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds
European Journal of Medicinal Chemistry 2015.0
Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and SNH reactions
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and evaluation of antitubercular activity of fluorinated 5-aryl-4-(hetero)aryl substituted pyrimidines
Bioorganic & Medicinal Chemistry 2016.0
Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents
MedChemComm 2015.0
Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of Antimycobacterium tuberculosis agents
European Journal of Medicinal Chemistry 2010.0
Facile synthesis of benzonitrile/nicotinonitrile based s-triazines as new potential antimycobacterial agents
European Journal of Medicinal Chemistry 2014.0
Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: Synthesis and in vitro anti-mycobacterial activity
Bioorganic & Medicinal Chemistry 2008.0
Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies
European Journal of Medicinal Chemistry 2017.0
Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors
European Journal of Medicinal Chemistry 2019.0
Synthesis and evaluation of in vitro antitubercular activity and antimicrobial activity of some novel 4H-chromeno[2,3-d]pyrimidine via 2-amino-4-phenyl-4H-chromene-3-carbonitriles
Medicinal Chemistry Research 2011.0